Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1,3 bis(1H imidazol 1 yl)benzene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107286199B reveals a novel dinuclear aryl ruthenium complex with high anticancer selectivity. Discover simplified synthesis routes and supply chain advantages for pharmaceutical manufacturing.
Patent CN107286199B reveals a high-yield synthesis of dinuclear aryl ruthenium complexes with superior anticancer activity and tunable water solubility for pharmaceutical applications.